Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Biostatistics (Oxford, England)|April 1, 2004
Generalized additive models for cancer mapping with incomplete covariatesJonathan L French, Matthew P WandJournal of Pharmacokinetics and Pharmacodynamics|April 2, 2010
Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlationJae Eun Ahn, Jonathan L FrenchBiometrics|December 24, 2002
Bayesian methods for a three-state model for rodent carcinogenicity studiesJonathan L French, Joseph G IbrahimJournal of Clinical Pharmacology|January 25, 2007
Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasisMatthew M Hutmacher, Ivan Nestorov, Tom Ludden, et al.Journal of Clinical Pharmacology|June 16, 2015
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic painMatthew M Hutmacher, Bill Frame, Raymond Miller, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 2, 2005
Collapsing mechanistic models: an application to dose selection for proof of concept of a selective irreversible antagonistMatthew M Hutmacher, Debu Mukherjee, Kenneth G Kowalski, et al.Statistics in Medicine|February 4, 2014
A linearization approach for the model-based analysis of combined aggregate and individual patient dataPatanjali Ravva, Mats O Karlsson, Jonathan L FrenchJournal of Pharmacokinetics and Pharmacodynamics|February 24, 2004
A two-part mixture model for longitudinal adverse event severity dataKenneth G Kowalski, Lynn McFadyen, Matthew M Hutmacher, et al.The AAPS Journal|January 29, 2013
Simultaneous pharmacokinetic model for rolofylline and both M1-trans and M1-cis metabolitesMark Stroh, Matthew M Hutmacher, Jianmei Pang, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 25, 2012
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary diseaseJace C Nielsen, Matthew M Hutmacher, Adriaan Cleton, et al.Pageof 4